Bluejay Diagnostics, Inc.
BJDX
$1.48
$0.032.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.39% | 25.54% | 22.46% | 14.43% | 12.10% |
| Total Depreciation and Amortization | -58.31% | -70.85% | -74.50% | -72.54% | -28.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -214.63% | 143.51% | -91.00% | 56.49% | -60.90% |
| Change in Net Operating Assets | -108.11% | -80.00% | -157.52% | -339.12% | -25.78% |
| Cash from Operations | 14.89% | 11.85% | 5.16% | -5.23% | 5.79% |
| Capital Expenditure | 99.72% | 31.99% | 56.45% | 53.95% | 70.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.72% | 31.99% | 56.45% | 53.95% | 70.23% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 95.30% | -43,004.44% | -40,308.33% | -50,518.18% | -57,925.00% |
| Issuance of Common Stock | -71.84% | 68.34% | 658.71% | 645.18% | 47,166.09% |
| Repurchase of Common Stock | -- | 73.33% | 99.32% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 79.44% | -0.63% | -344.11% | -325.88% | -11,198.50% |
| Cash from Financing | -71.46% | 89.37% | 825.35% | 790.37% | 21,716.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -222.22% | 111.04% | 126.48% | 108.27% | 128.88% |